GnRH agonist trigger and ovarian hyperstimulation syndrome: Relook at 'freeze-all strategy'

Reproductive BioMedicine Online

Volumn 29, Issue 3, 2014, Pages 392-394

  Ling, Liza Ping ^a   Phoon, Jessie Wai Leng ^a   Lau, Matthew Sie Kuei ^a   Chan, Jerry Kok Yen ^a   Viardot Foucault, Veronique ^a   Tan, Tse Yeun ^a   Nadarajah, Sadhana ^a   Tan, Heng Hao ^a  

^a KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

Author keywords

AMH level; GnRH agonist; GnRH antagonist protocol; Ovarian hyperstimulation syndrome

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL VALERATE; GONADORELIN ANTAGONIST; INFUSION FLUID; LEUPRORELIN; PROGESTERONE; RECOMBINANT FOLLITROPIN; FERTILITY PROMOTING AGENT; GONADORELIN;

ABDOMINAL DISTENSION; ABDOMINAL DRAIN; ADULT; ARTICLE; ASCITES; ASCITES FLUID; CASE REPORT; CLINICAL PROTOCOL; DYSPNEA; FEMALE; FERTILIZATION IN VITRO; HOSPITALIZATION; HUMAN; INTRAUTERINE INSEMINATION; OOCYTE; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY; RETROSPECTIVE STUDY; TWIN PREGNANCY; ADVERSE EFFECTS; AGONISTS; CHEMICALLY INDUCED; CRYOPRESERVATION; PROCEDURES;

ADULT; CRYOPRESERVATION; FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION;

EID: 84926217932     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2014.05.012     Document Type: Article

References (11)

1. Al-Inany, H.G., Abou-Setta, A.M., Aboulghar, M., 2006. Gonadotrophinreleasing hormone antagonists for assisted conception. Cochrane Database Syst. Rev. (3), CD001750.
2. Chong, Y.S., Chan, M.L.H., Tan, H.H., Nadarajah, S., 2014. Human embryo crypreservation:one-step slow freezing does it all? J. Assist. Reprod. Genet. doi:10.1007/s108150-140-2388.
3. Devroey, P., Polyzos, N.P., Blockeel, C., 2011. An OHSS-Free Clinic by segmentation of IVF treatment. Hum. Reprod. 26 (10), 2593-2597.
4. Griesinger, G., Schultz, L., Bauer, T., Broessner, A., Frambach, T., Kissler, S., 2011. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a 'freeze-all' strategy: a prospective multicentric study. Fertil. Steril. 95, 2029-2033.
5. Humaidan, P., Kol, S., Papanikolaou, E.G. (on behalf of the 'The Copenhagen GnRH Agonist Triggering Workshop Group), 2011. GnRH agonist for triggering of final oocyte maturation:time for a change in practice? Hum. Reprod. Update 17, 5105-5124.
6. Kol, S., Humaidan, P., 2013. GnRH agonist triggering:recent developments. Reprod. Biomed. Online 26, 226-230.
7. Lainas, G.T., Kolibianakis, E.M., Sfontouris, I.A., Zorzovilis, I.Z., Petsas, G.K., Tarlatzi, T.B., Tarlatzis, B.C., Lainas, T.G., 2012. Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: an observational cohort study. Reprod. Biol. Endocrinol. 10, 69. doi:10.1186/14777-8271-06-9.
8. Lee, T.H., Liu, C.H., Huang, C.C., Wu, Y.L., Shih, Y.T., Ho, H.N., Yang, Y.S., Lee, M.S., 2008. Serum anti mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum. Reprod. 23, 160-167.
9. Mathur, R., Evbuomwan, I., Jenkins, J., 2005. Prevention and management of ovarian hyperstimulation syndrome. Curr. Obstet. Gynecol. 15, 132-138.
10. Navot, D., Bergh, P.A., Laufer, N., 1992. Ovarian hyperstimulation syndrome in novel reproduction technologies:prevention and treatment. Fertil. Steril. 58, 249-261.
11. O'Brien, T.J., Kalmin, M.M., Harralson, A.F., Clark, A.M., Gindoff, I., Simmens, S.J., Frankfurter, D., Gindoff, P., 2013. Association between the luteinizing hormone/chorionic gonadotropin receptor(LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation. Reprod. Biol. Endocrinol. 11, 71.